Testing Novel Nanoparticles for Antagonizing HIV Latency

Jerome Zack of the University of California, Los Angeles in the U.S. will test nanoparticles for their ability to specifically activate HIV from latently infected cells. Once the latent cells express viral proteins, host immune responses and targeted therapies can be used to kill the cell. If successful, this project could provide an effective approach to eliminate an important viral reservoir from HIV infected individuals.